Health In Tech, Inc.
NASDAQ Capital MarketTotal Valuation
Health In Tech, Inc. carries a market capitalization of 34.04M, placing it among publicly traded companies globally. Its enterprise value stands at 59.87M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 34.04M |
| Enterprise Value | 59.87M |
Share Statistics
Health In Tech, Inc. currently has 65.56M shares outstanding.
| Shares Outstanding | 65.56M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Health In Tech, Inc. trades at a trailing price-to-earnings ratio of 192.85. The price-to-sales ratio is 1.80, and the price-to-book ratio stands at 3.39.
| PE Ratio | 192.85 |
| PS Ratio | 1.80 |
| PB Ratio | 3.39 |
| P/TBV Ratio | 5.36 |
| P/FCF Ratio | -23.34 |
| P/OCF Ratio | -11.55 |
Enterprise Valuation
On an enterprise value basis, Health In Tech, Inc. trades at an EV/EBITDA multiple of 1,592.01 and an EV/FCF ratio of 70.16. The EV/Sales ratio of 1.82 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 180.53 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.82 |
| EV / EBITDA | 1,592.01 |
| EV / EBIT | 180.53 |
| EV / FCF | 70.16 |
Financial Position
Health In Tech, Inc. maintains a current ratio of 2.18, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.18 |
| Quick Ratio | 1.93 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | -0.03 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -21.96 |
| Return on Assets (ROA) | -15.25 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 11.76 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Health In Tech, Inc. has paid -1.28M in income taxes, reflecting an effective tax rate of 24.67.
| Income Tax | -1.28M |
| Effective Tax Rate | 24.67 |
Stock Price Statistics
Health In Tech, Inc.'s stock has declined approximately -79.9653% over the past 52 weeks. The 50-day moving average sits at 0.89, while the 200-day moving average is 1.20.
| Beta (5Y) | N/A |
| 52-Week Price Change | -79.9653% |
| 50-Day Moving Average | 0.89 |
| 200-Day Moving Average | 1.20 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Health In Tech, Inc. generated 32.83M in revenue and converted that into -3.95M in net income, yielding earnings per share of -0.07. EBITDA reached -3.92M, while operating income came in at -5.27M.
| Revenue | 32.83M |
| Gross Profit | 17.70M |
| Operating Income | -5.27M |
| Pretax Income | -5.23M |
| Net Income | -3.95M |
| EBITDA | -3.92M |
| EBIT | -5.27M |
| Earnings Per Share (EPS) | -0.07 |
Balance Sheet
Health In Tech, Inc. holds 6.51M in cash and equivalents against 102,938.00 in total debt, resulting in a net debt position of -6.51M. Total book value stands at 19.55M, with working capital of 11.80M providing operational flexibility.
| Cash & Cash Equivalents | 6.51M |
| Total Debt | 102,938.00 |
| Net Debt | -6.51M |
| Equity (Book Value) | 19.55M |
| Book Value Per Share | 0.30 |
| Working Capital | 11.80M |
Cash Flow
Health In Tech, Inc. produced -5.11M in operating cash flow over the past twelve months. After subtracting -2.54M in capital expenditures, free cash flow totaled -7.64M - equivalent to -0.13 per share.
| Operating Cash Flow | -5.11M |
| Capital Expenditures | -2.54M |
| Free Cash Flow | -7.64M |
| FCF Per Share | -0.13 |
Margins
Health In Tech, Inc. operates with a gross margin of 53.93, reflecting its pricing power and cost economics. The operating margin of -16.07 and net profit margin of -12.03 provide insight into operational efficiency.
| Gross Margin | 53.93 |
| Operating Margin | -16.07 |
| Pretax Margin | -15.94 |
| Profit Margin | -12.03 |
| EBITDA Margin | -11.95 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -8.99 |
| FCF Yield | -4.29 |
Scores
Health In Tech, Inc. posts an Altman Z-Score of 5.36, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.36 |